APA and advocacy organizations like the National Alliance on Mental Illness
(NAMI) have shared interests that demand—and create the opportunity
for—wide-ranging cooperation.
So said psychiatrist, patient, and NAMI President Suzanne Vogel-Scibilia,
M.D., at the Opening Session of APA's 58th Institute on Psychiatric Services
in New York last month. She spoke at the invitation of APA President Pedro
Ruiz, M.D.
With 1,100 chapters nationwide and with 30 percent of its members“
primary consumers” of mental health care, NAMI is believed to be
the largest grass-roots mental health consumer advocacy organization in the
United States.
Vogel-Scibilia noted that collaboration between the two organizations has
intensified in recent years, as evidenced by the number of “NAMI
doctors” in APA's ranks. NAMI doctors are clinicians who have devoted
themselves to the care of people with serious and persistent mental illness.“
When I look at the leadership of APA and the American Association of
Community Psychiatrists, I see a lot of NAMI doctors,” she said.
Vogel-Scibilia occupies a unique perspective from which to advocate for the
marriage of clinician and consumer interests in mental health advocacy. She
was diagnosed with bipolar disorder with psychotic features at age 15, is the
mother of children with bipolar disorder, and is medical director of Beaver
County Psychiatric Services—a community mental health center in Beaver,
Pa.—in addition to being president of NAMI.
“I am probably the first NAMI president to wear three hats,”
she said. “I am a clinical psychiatrist and work in a community mental
health center. The majority of our patients are indigent and have no health
insurance, or they are on Medicaid or have some skeletal coverage. About 40
percent of our patients have managed care. So we see a broad range of patients
from kids to geriatric age, and everyone has serious and persistent mental
illness.”
She added that children and other members of her family have mental
illness, so she has the perspective of the parent and family member.
“I have bipolar disorder with psychotic features,”
Vogel-Scibilia said. “I have had severe psychotic depression, three
suicide attempts, and a postpartum catatonic episode while I was in residency.
So I have seen the bad aspects of mental illness personally, and I have also
seen recovery.
“One of the biggest problems in mental health advocacy is that people
who want to defeat the goals of APA and NAMI do that by splitting the field.
So we need closer connections.”
Drawing on her experience as patient, family member, and clinician,
Vogel-Scibilia outlined six areas where APA, NAMI, and other consumer mental
health advocacy organizations have shared interests calling for collaboration.
In addition to stigma and the criminalization of mentally ill individuals,
these areas include the following:
Translation of research advances to clinical practice: “The
advances in psychiatric research in the last 10 or 15 years have really
offered the opportunity for targeted treatment of people with mental
illness,” Vogel-Scibilia said. “However, many times discoveries at
the bench do not get translated into clinical trials that would be applicable
to our population. And the next step is dissemination of [new knowledge] out
to the grass roots. The lag time is very much a source of frustration for
advocates.”
Access to services: Eliminating barriers to care, such as
restrictive formularies and copays, is necessary to ensure that patients“
can get the treatment they need, when they need it, and in the right
amount.”
Metabolic symptoms associated with second-generation antipsychotics:
As a patient Vogel-Scibilia cited her own struggles with weight gain and
testified to the effects that metabolic symptoms have on the patients she
treats. “As a consumer I feel like I am on death row,” she said.“
I may have a stay of execution because I don't drink and smoke. But I
find that in my practice patients don't die of suicide or homicide or
accidents, but from metabolic complications.”
Treatment of comorbid medical conditions in people with mental
illness: Vogel-Scibilia said that the medical symptoms of patients with
mental illness are frequently disregarded, and she urged psychiatrists to play
a larger role in the monitoring not only of metabolic symptoms but of
patients' health in general.
Translation of research advances to clinical practice: “The
advances in psychiatric research in the last 10 or 15 years have really
offered the opportunity for targeted treatment of people with mental
illness,” Vogel-Scibilia said. “However, many times discoveries at
the bench do not get translated into clinical trials that would be applicable
to our population. And the next step is dissemination of [new knowledge] out
to the grass roots. The lag time is very much a source of frustration for
advocates.”
Access to services: Eliminating barriers to care, such as
restrictive formularies and copays, is necessary to ensure that patients“
can get the treatment they need, when they need it, and in the right
amount.”
Metabolic symptoms associated with second-generation antipsychotics:
As a patient Vogel-Scibilia cited her own struggles with weight gain and
testified to the effects that metabolic symptoms have on the patients she
treats. “As a consumer I feel like I am on death row,” she said.“
I may have a stay of execution because I don't drink and smoke. But I
find that in my practice patients don't die of suicide or homicide or
accidents, but from metabolic complications.”
Treatment of comorbid medical conditions in people with mental
illness: Vogel-Scibilia said that the medical symptoms of patients with
mental illness are frequently disregarded, and she urged psychiatrists to play
a larger role in the monitoring not only of metabolic symptoms but of
patients' health in general.
She recalled her experience as a patient when she went to the hospital with
shortness of breath. Because she'd had previous bouts of pneumonia, she
suggested to the physician—who was unaware that Vogel-Scibilia was a
doctor—that she needed an X-ray. But when the physician saw her
medications, which included prescriptions for bipolar illness with psychotic
features, he insisted that her symptoms were those of a panic attack. Later,
an X-ray confirmed her self-diagnosis.
“People with mental illness in the medical setting are thought not to
have medical illness,” she said. “Because of the medications I was
on, I can't convince someone I'm medically ill. I didn't need to have a sign
on my back saying, `Misread my symptoms.' All they had to do was see my
meds.” ▪